UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

Optic neuritis

Lancet neurology, 2014, Vol.13 (1), p.83-99

2014

Volltextzugriff (PDF)

Helsinki Stroke Model Is Transferrable With "Real-World" Resources and Reduced Stroke Thrombolysis Delay to 34 min in Christchurch

Frontiers in neurology, 2018-04, Vol.9, p.290-290

2018

Volltextzugriff (PDF)

Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis

Frontiers in neurology, 2018-08, Vol.9, p.690-690

2018

Volltextzugriff (PDF)

The latitude gradient for multiple sclerosis prevalence is established in the early life course

Brain (London, England : 1878), 2021-08, Vol.144 (7), p.2038-2046

2021

Volltextzugriff (PDF)

Multiple sclerosis mortality in New Zealand: a nationwide prospective study

Journal of neurology, neurosurgery and psychiatry, 2023-07, Vol.94 (7), p.511

2023

Volltextzugriff (PDF)

Incidence and prevalence of NMOSD in Australia and New Zealand

Journal of neurology, neurosurgery and psychiatry, 2017-08, Vol.88 (8), p.632

2017

Volltextzugriff (PDF)

Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2014-05, Vol.85 (5), p.544-551

2014

Volltextzugriff (PDF)

The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis

Multiple sclerosis, 2022-04, Vol.28 (5), p.831-841

2022

Volltextzugriff (PDF)

Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis

Psychiatry research. Neuroimaging, 2015-12, Vol.234 (3), p.352-361

2015

Volltextzugriff (PDF)

Increased Large Vessel Occlusive Strokes After the Christchurch March 15, 2019, Terror Attack

Neurology, 2021-01, Vol.96 (4), p.171

2021

Volltextzugriff (PDF)

Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand

The European journal of health economics, 2023-08, Vol.24 (6), p.939-950

2023

Volltextzugriff (PDF)

Multiple sclerosis in New Zealand

Journal of clinical neuroscience, 2014-08, Vol.21 (8), p.1288-1291

2014

Volltextzugriff (PDF)

MS prevalence in New Zealand, an ethnically and latitudinally diverse country

Multiple sclerosis, 2010-12, Vol.16 (12), p.1422-1431

2010

Volltextzugriff (PDF)

The neuro-otology of Susac syndrome

Journal of neurology, 2020-12, Vol.267 (12), p.3711-3722

2020

Volltextzugriff (PDF)

Multiple sclerosis in New Zealand Māori

Multiple sclerosis, 2014-12, Vol.20 (14), p.1892-1895

2014

Volltextzugriff (PDF)

An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand

Multiple sclerosis, 2016-04, Vol.22 (5), p.705-707

2016

Volltextzugriff (PDF)

Response to treatment in NMOSD: the Australasian experience

Multiple sclerosis and related disorders, 2022-02, Vol.58, p.103408-103408, Article 103408

2022

Volltextzugriff (PDF)

A new era in the treatment of multiple sclerosis

Medical journal of Australia, 2015-08, Vol.203 (3), p.139-141

2015

Volltextzugriff (PDF)

Disability profile of multiple sclerosis in New Zealand

Journal of clinical neuroscience, 2016-06, Vol.28, p.97-101

2016

Volltextzugriff (PDF)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

Journal of clinical neuroscience, 2014-11, Vol.21 (11), p.1857-1865

2014

Volltextzugriff (PDF)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

Journal of clinical neuroscience, 2014-11, Vol.21 (11), p.1847-1856

2014

Volltextzugriff (PDF)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

Journal of clinical neuroscience, 2014-11, Vol.21 (11), p.1835-1846

2014

Volltextzugriff (PDF)

Acute inflammatory encephalomyelitis following Campylobacter enteritis associated with high titre antiganglioside GM1 IgG antibodies

Journal of clinical neuroscience, 2009-04, Vol.16 (4), p.597-598

2009

Volltextzugriff (PDF)

Geographical variations in sex ratio trends over time in multiple sclerosis

PloS one, 2012-10, Vol.7 (10), p.e48078-e48078

2012

Volltextzugriff (PDF)

418: Tuberculous (TB) meningitis in Auckland Hospital 1965–2004: epidemiology, delays in treatment and complications

Journal of clinical neuroscience, 2008-03, Vol.15 (3), p.347-348

2008

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(116)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Optic neuritis

Helsinki Stroke Model Is Transferrable With "Real-World" Resources and Reduced Stroke Thrombolysis Delay to 34 min in Christchurch

Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis

The latitude gradient for multiple sclerosis prevalence is established in the early life course

Multiple sclerosis mortality in New Zealand: a nationwide prospective study

Incidence and prevalence of NMOSD in Australia and New Zealand

Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis

The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis

Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis

Increased Large Vessel Occlusive Strokes After the Christchurch March 15, 2019, Terror Attack

Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand

Multiple sclerosis in New Zealand

MS prevalence in New Zealand, an ethnically and latitudinally diverse country

The neuro-otology of Susac syndrome

Multiple sclerosis in New Zealand Māori

An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand

Response to treatment in NMOSD: the Australasian experience

A new era in the treatment of multiple sclerosis

Disability profile of multiple sclerosis in New Zealand

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

Acute inflammatory encephalomyelitis following Campylobacter enteritis associated with high titre antiganglioside GM1 IgG antibodies

Geographical variations in sex ratio trends over time in multiple sclerosis

418: Tuberculous (TB) meningitis in Auckland Hospital 1965–2004: epidemiology, delays in treatment and complications

Suchergebnisse filtern